ChemicalBook >> CAS DataBase List >>GDC-0834

GDC-0834

CAS No.
1133432-50-4
Chemical Name:
GDC-0834
Synonyms
GDC-0834 (S-enantiomer);GDC 0834 S enantiomer,GDC0834 Senantiomer;Benzo[b]thiophene-2-carboxamide, N-[3-[6-[[4-[(2S)-1,4-dimethyl-3-oxo-2-piperazinyl]phenyl]amino]-4,5-dihydro-4-methyl-5-oxo-2-pyrazinyl]-2-methylphenyl]-4,5,6,7-tetrahydro-
CBNumber:
CB82677398
Molecular Formula:
C33H36N6O3S
Molecular Weight:
596.74
MDL Number:
MFCD26142642
MOL File:
1133432-50-4.mol
Last updated:2024-07-02 08:55:20

GDC-0834 Properties

Density 1.35±0.1 g/cm3(Predicted)
storage temp. Store at -20° C
solubility Soluble in DMSO
form Solid
pka 12.46±0.70(Predicted)
color Brown to reddish brown

GDC-0834 price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-6128 GDC-0834S-enantiomer 95.11% 1133432-50-4 2mg $264 2021-12-16 Buy
ChemScene CS-6128 GDC-0834S-enantiomer 95.11% 1133432-50-4 5mg $420 2021-12-16 Buy
ChemScene CS-6128 GDC-0834S-enantiomer 95.11% 1133432-50-4 10mg $600 2021-12-16 Buy
Crysdot CD11348722 GDC-0834S-Enantiomer 95+% 1133432-50-4 50mg $508 2021-12-16 Buy
Crysdot CD11348722 GDC-0834S-Enantiomer 95+% 1133432-50-4 5mg $133 2021-12-16 Buy
Product number Packaging Price Buy
CS-6128 2mg $264 Buy
CS-6128 5mg $420 Buy
CS-6128 10mg $600 Buy
CD11348722 50mg $508 Buy
CD11348722 5mg $133 Buy

GDC-0834 Chemical Properties,Uses,Production

Biological Activity

GDC-0834 is a potent and selective Bruton's tyrosine kinase (Btk) inhibitor, The IC50 values in biochemical and cellular assays is 5.9 and 6.4 nM. The in vivo IC50 values in mouse and rat are 1.1 and 5.6 μM, respectively. B cell antigen receptor (BCR) stimulation phosphorylated and activated Btk. Btk gene defects result in a disease named as X-linked agammaglobulinemia which profoundly decreased mature B cells due to a block in B cell development.

in vivo

In a rat collagen-induced arthritis (CIA) model, administration of GDC-0834 (30-100 mg/kg) model resulted in a dose-dependent decrease of ankle swelling and reduction of morphologic pathology.In PXB chimeric mice with humanized liver, GDC-0834 exhibited low clearance. in most samples from the cohorts dosed orally at 35 and 105 mg GDC-0834, plasma concentrations of GDC-0834 in humans were below the limit of quantitation (<1 ng/ml). High interest in a BTK inhibitor for clinical evaluation and uncertainty in human pharmacokinetic prediction prompted an investigational new drug strategy, in which GDC-0834 was rapidly advanced to a single-dose human clinical trial.

GDC-0834 Preparation Products And Raw materials

Raw materials

Preparation Products

GDC-0834 Suppliers

Global( 11)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 19892 58
Aladdin Scientific
+1-+1(833)-552-7181 sales@aladdinsci.com United States 52927 58
Jinan Trio PharmaTech Co., Ltd. +86 (531) 88811783 sales@trio-pharmatech.com (International market) China 1856 62
MedChemexpress LLC 021-58955995 sales@medchemexpress.cn United States 4863 58
Musechem +1-800-259-7612 info@musechem.com United States 4662 60
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767 sales@chemegen.com China 11289 58
Absin Bioscience Inc. 021-38015121 15000105423 wulan@absin.cn China 24734 58
MedBioPharmaceutical Technology Inc 021-69568360 18916172912 order@med-bio.cn China 8141 58
Shanghai Maclean Biochemical Technology Co., LTD 021-50706066 15221275939 shenlinxing@macklin.cn China 29802 58
RD International Technology Co., Limited 18024082417 market@ubiochem.com China 9268 58
GDC-0834 (S-enantiomer) Benzo[b]thiophene-2-carboxamide, N-[3-[6-[[4-[(2S)-1,4-dimethyl-3-oxo-2-piperazinyl]phenyl]amino]-4,5-dihydro-4-methyl-5-oxo-2-pyrazinyl]-2-methylphenyl]-4,5,6,7-tetrahydro- GDC 0834 S enantiomer,GDC0834 Senantiomer 1133432-50-4